An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis
NCT02195440
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C Virus-infected Cirrhosis
Interventions
DRUG:
PRI-724
Sponsor
Komagome Hospital
Collaborators
[object Object]
[object Object]